Related Experiment Video
Updated: May 11, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Pyrvinium targets autophagy addiction to promote cancer cell death
Longfei Deng1, Yunlong Lei, Rui Liu
1The State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Abstract:
Autophagy is a cellular catabolic process by which long-lived proteins and damaged organelles are degradated by lysosomes. Activation of autophagy is an important survival mechanism that protects cancer cells from various stresses, including anticancer agents. Recent studies indicate that pyrvinium pamoate, an FDA-approved antihelminthic drug, exhibits wide-ranging anticancer activity. Here we demonstrate that pyrvinium inhibits autophagy both in vitro and in vivo. We further demonstrate that the inhibition of autophagy is mammalian target of rapamycin independent but depends on the transcriptional inhibition of autophagy genes. Moreover, the combination of pyrvinium with autophagy stimuli improves its toxicity against cancer cells, and pretreatment of cells with 3-MA or siBeclin1 partially protects cells from pyrvinium-induced cell death under glucose starvation, suggesting that targeted autophagy addiction is involved in pyrvinium-mediated cytotoxicity. Finally, in vivo studies show that the combination therapy of pyrvinium with the anticancer and autophagy stimulus agent, 2-deoxy-D-glucose (2-DG), is significantly more effective in inhibiting tumor growth than pyrvinium or 2-DG alone. This study supports a novel cancer therapeutic strategy based on targeting autophagy addiction and implicates using pyrvinium as an autophagy inhibitor in combination with chemotherapeutic agents to improve their therapeutic efficacy.
Insights
Pyrvinium pamoate, an antihelminthic drug, inhibits cancer cell autophagy by reducing gene expression. Combining pyrvinium with autophagy stimuli enhances its anticancer effects, suggesting a new therapeutic strategy targeting autophagy addiction.
Area of Science:
- Cell Biology
- Oncology
- Pharmacology
Background:
- Autophagy is a cellular process crucial for cancer cell survival under stress.
- Pyrvinium pamoate, an antihelminthic, shows potential anticancer activity.
- Understanding pyrvinium's mechanism is key to developing new cancer therapies.
Purpose of the Study:
- To investigate the effect of pyrvinium pamoate on autophagy in cancer cells.
- To elucidate the mechanism by which pyrvinium inhibits autophagy.
- To evaluate the therapeutic potential of combining pyrvinium with autophagy-modulating agents.
Main Methods:
- In vitro and in vivo studies using cancer cell lines.
- Analysis of autophagy gene expression and mammalian target of rapamycin (mTOR) pathway.
- Combination therapy studies with autophagy inducers like 2-deoxy-D-glucose (2-DG) and inhibitors like 3-MA.
Main Results:
- Pyrvinium pamoate effectively inhibits autophagy in cancer cells, independent of mTOR.
- Inhibition of autophagy by pyrvinium occurs via transcriptional downregulation of autophagy genes.
- Combination of pyrvinium with autophagy stimuli (e.g., 2-DG) significantly enhances cancer cell toxicity and inhibits tumor growth in vivo.
- Evidence suggests cancer cells can become addicted to autophagy, making them vulnerable to pyrvinium.
Conclusions:
- Pyrvinium pamoate is a potent autophagy inhibitor with anticancer properties.
- Targeting autophagy addiction with pyrvinium offers a novel therapeutic strategy.
- Combination therapy of pyrvinium with other anticancer agents or autophagy inducers may improve treatment efficacy.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

